Analyzed by flow cytometry, CD11b+CD33+HLA- MDSCs percentages in peripheral blood were found to be significantly elevated in gastric cancer patients (6.93 ± 1.30 %) than control subjects (1.92 ± 0.77 %, p<0.001) (Figure 1). The gene discussed is CD33; the disease is gastric cancer.